Targeted Delivery of Chloroquine to Plasmacytoid Dendritic Cells Enhances Inhibition of the Type I Interferon Response
M. E. Allen, A. Golding, V. Rus, N. B. Karabin, S. Li, C. Lescott, S. Bobbala, E. A. Scott, G. L. Szeto
This study shows that delivering chloroquine via nanocarriers specifically to plasmacytoid dendritic cells reduces type I interferon production in SLE models.
ACS Biomaterials Science & Engineering · Nov 23, 2021Peer-reviewedBioengineering